Workflow
QIAGEN(QGEN)
icon
Search documents
QIAGEN(QGEN) - 2021 Q3 - Earnings Call Transcript
2021-11-04 19:55
QIAGEN N.V. (NYSE:QGEN) Q3 2021 Earnings Conference Call November 4, 2021 9:30 AM ET Company Participants John Gilardi - Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Falko Friedrichs - Deutsche Bank Tycho Peterson - JPMorgan Daniel Wendorff - Oddo BHF Derik de Bruin - Bank of America Scott Bardo - Berenberg Jack Meehan - Nephron Dan Brennan - Cowen Operator Ladies and gentl ...
QIAGEN (QGEN) Investor Presentation - Slideshow
2021-05-18 22:21
Sample to Insight Investor Presentation Q2 2021 Thierry Bernard Chief Executive Officer Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent t ...
QIAGEN(QGEN) - 2021 Q1 - Earnings Call Transcript
2021-05-05 05:28
QIAGEN N.V. (NYSE:QGEN) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants John Gilardi – Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Phoebe Loh – Senior Director-Investor Relations Conference Call Participants Patrick Donnelly – Citi Daniel Wendorff – Commerzbank Scott Bardo – Berenberg Doug Schenkel – Cowen John Sourbeer – UBS Falko Friedrichs – Deutsche Bank Brian Weinstei ...
QIAGEN(QGEN) - 2021 Q1 - Earnings Call Presentation
2021-05-04 16:42
Sample to Insight First quarter 2021 results May 4, 2021 Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements conta ...
QIAGEN(QGEN) - 2020 Q4 - Annual Report
2021-03-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...
QIAGEN(QGEN) - 2020 Q4 - Earnings Call Transcript
2021-02-10 20:10
QIAGEN N.V. (NYSE:QGEN) Q4 2020 Earnings Conference Call February 10, 2021 9:00 AM ET Company Participants John Gilardi - Vice President, Head of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Daniel Wendorff - Commerzbank Brian Weinstein - William Blair Scott Bardo - Berenberg Doug Schenkel - Cowen Steve Beuchaw - Wolfe Research Derik De Bruin - Bank of America Dan ...
QIAGEN(QGEN) - 2019 Q4 - Annual Report
2020-02-28 22:53
or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F or ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission File Number 001-38332 ___________________ ...
QIAGEN(QGEN) - 2019 Q4 - Earnings Call Transcript
2020-02-06 03:10
QIAGEN N.V. (NYSE:QGEN) Q4 2019 Results Conference Call February 5, 2020 9:00 AM ET Company Participants John Gilardi - VP of Corporate Communications and Investor Relations Thierry Bernard - Interim CEO Roland Sackers - Chief Financial Officer Phoebe Loh - Investor Relations Conference Call Participants Bill Quirk - Piper Sandler Tycho Peterson - JPMorgan Steve Beuchaw - Wolf Research Doug Schenkel - Cowen Dan Brennan - UBS Scott Bardo - Berenberg Brian Weinstein - William Blair Daniel Arias - Stifel Opera ...
QIAGEN(QGEN) - 2019 Q3 - Earnings Call Presentation
2019-11-05 19:28
Research lab at the University of Houston in Houston, Texas Third quarter and first nine months 2019 results October 31, 2019 Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Secur ...
QIAGEN(QGEN) - 2019 Q3 - Earnings Call Transcript
2019-10-31 20:26
QIAGEN N.V. (NYSE:QGEN) Q3 2019 Earnings Conference Call October 31, 2019 9:00 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Thierry Bernard - Interim Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Steve Beuchaw - Wolfe Research Tycho Peterson - JPMorgan Luke Sergott - Evercore ISI Scott Bardo - Berenberg Bank Bill Quirk - Piper Jaffray Daniel Wendorff - Commerzbank Dan Brennan - UBS Jack Meehan - Barc ...